Article

Mmarketwatch.com on 2020-09-28 13:32

Biotech Oncorus to offer 5.8 million shares in planned IPO, priced at $14 to $16 each

Biotech Oncorus Inc. undefined set terms for its initial public offering on Monday with plans to offer 5.8 million shares priced at $14 to $16 each. The...

Piper Sandler

Related news

MBiotech Nurix Therapeutics to offer 11 million shares in planned IPO, priced at $17 to $18 each marketwatch.com
Needham
MBiotech Inhibrx to offer 6 million shares in planned IPO, priced at $16 to $18 each marketwatch.com
MBiotech Alzheon to offer 6 million shares in planned IPO priced at $4 to $6 each marketwatch.com
MHarmony Biosciences to offer 4.65 million shares in planned IPO, priced at $20 to $23 each marketwatch.com
MProgenity to offer 6.7 million shares in planned IPO priced at $14 to $16 each marketwatch.com
MBiotech Arvinas to offer 6.7 million shares in IPO priced at $14 to $16 each marketwatch.com
MBiotech Cibus to offer 6.7 million shares in IPO, priced at $14 to $16 each marketwatch.com
MSchrödinger to offer 10 million shares in planned IPO, priced at $14 to $16 each marketwatch.com
MCentogene to offer 4 million shares in planned IPO priced at $14 to $16 each marketwatch.com
MBeam Therapeutics to offer 6.25 million shares in planned IPO priced at $15 to $17 each marketwatch.com
MGeneration Bio to offer 7.4 million shares in planned IPO, priced at $16 to $18 each marketwatch.com
MIGM Biosciences to offer 7.8 million shares in planned IPO, priced at $15 to $17 each marketwatch.com
M10x Genomics to offer 9 million shares in planned IPO, priced at $31 to $35 each marketwatch.com
MPandion Therapeutics upsizes planned IPO, to offer 7 million shares priced at $16 to $18 each marketwatch.com
MLaird Superfood to offer 2.2 million shares in planned IPO, priced at $18 to $20 each marketwatch.com
MLyra Therapeutics to offer 3.5 million shares in planned IPO, priced at $14 to $16 each marketwatch.com
MADC Therapeutics to offer 8.1 million shares in planned IPO, priced at $23 to $26 each marketwatch.com
MAssetMark Financial to offer 12.5 million shares in planned IPO, priced at $19 to $21 each marketwatch.com
MRapt Therapeutics to offer 3 million shares in planned IPO priced at $12 to $14 each marketwatch.com
MPandion Therapeutics to offer 5.5 million shares in planned IPO, priced at $16 to $18 each marketwatch.com